A novel prognostic model for transplant-free survival in primary sclerosing cholangitis REPLY

Elizabeth C. Goode; Gideon M. Hirschfield; Simon M. Rushbrook

doi:10.1002/hep.30963

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis REPLY

Elizabeth C. Goode, Gideon M. Hirschfield, Simon M. Rushbrook

Research output: Contribution to journal › Comment/debate

12 Downloads (Pure)

Abstract

Primary sclerosing cholangitis (PSC) is a rare liver disease with high clinical burden and significant heterogeneity in outcome. The UK-PSC risk scores(1), based upon a national observational cohort study of >1000 patients from across the UK, provide a robust evaluation of PSC risk for individual patients based on clinical predictors of outcome.

Original language	English
Pages (from-to)	399-400
Number of pages	2
Journal	Hepatology
Volume	71
Issue number	1
Early online date	24 Sep 2019
DOIs	https://doi.org/10.1002/hep.30963
Publication status	Published - Jan 2020

Access to Document

10.1002/hep.30963

Goode_et_al-2019-HepatologyAccepted author manuscript, 85.6 KB

Cite this

@article{ff50025992624cfa88174285036a7f8e,

title = "A novel prognostic model for transplant-free survival in primary sclerosing cholangitis REPLY",

abstract = "Primary sclerosing cholangitis (PSC) is a rare liver disease with high clinical burden and significant heterogeneity in outcome. The UK-PSC risk scores(1), based upon a national observational cohort study of >1000 patients from across the UK, provide a robust evaluation of PSC risk for individual patients based on clinical predictors of outcome.",

author = "Goode, {Elizabeth C.} and Hirschfield, {Gideon M.} and Rushbrook, {Simon M.}",

note = "{\textcopyright} 2019 by the American Association for the Study of Liver Diseases.",

year = "2020",

month = jan,

doi = "10.1002/hep.30963",

language = "English",

volume = "71",

pages = "399--400",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - A novel prognostic model for transplant-free survival in primary sclerosing cholangitis REPLY

AU - Goode, Elizabeth C.

AU - Hirschfield, Gideon M.

AU - Rushbrook, Simon M.

PY - 2020/1

Y1 - 2020/1

N2 - Primary sclerosing cholangitis (PSC) is a rare liver disease with high clinical burden and significant heterogeneity in outcome. The UK-PSC risk scores(1), based upon a national observational cohort study of >1000 patients from across the UK, provide a robust evaluation of PSC risk for individual patients based on clinical predictors of outcome.

AB - Primary sclerosing cholangitis (PSC) is a rare liver disease with high clinical burden and significant heterogeneity in outcome. The UK-PSC risk scores(1), based upon a national observational cohort study of >1000 patients from across the UK, provide a robust evaluation of PSC risk for individual patients based on clinical predictors of outcome.

UR - http://www.scopus.com/inward/record.url?scp=85077847602&partnerID=8YFLogxK

U2 - 10.1002/hep.30963

DO - 10.1002/hep.30963

M3 - Comment/debate

C2 - 31550385

VL - 71

SP - 399

EP - 400

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis REPLY

Abstract

Access to Document

Other files and links

Cite this